Target
Induced myeloid leukemia cell differentiation protein Mcl-1 [171-323]
Ligand
BDBM608368
Substrate
n/a
Meas. Tech.
Inhibition of Mcl-1 by fluorescence polarization (FP) assay
IC50
15.0±n/a nM
Citation
 Chen, HChen, WLi, CLi, DJing, YTang, GZhou, YWang, SYang, C Macrocyclic indoles as Mcl-1 inhibitors US Patent  US11691989 Publication Date 7/4/2023 
Target
Name:
Induced myeloid leukemia cell differentiation protein Mcl-1 [171-323]
Synonyms:
Induced myeloid leukemia cell differentiation protein Mcl-1 (171-323)
Type:
Enzyme Catalytic Domain
Mol. Mass.:
17540.76
Organism:
Homo sapiens (Human)
Description:
Q07820[171-323]
Residue:
153
Sequence:
EDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVED
  
Inhibitor
Name:
BDBM608368
Synonyms:
(Z)-15-chloro-96-fluoro-21,25,61-trimethyl-13- (trifluoromethyl)-11H,21H,61H-10-oxa-4,8- dithia-1(4,1)-indola-2(4,3),6(3,5)-dipyrazola- 9(3,1)-naphthalenacyclotridecaphane-12- carboxylic acid | US11691989, Compound 24
Type:
Small organic molecule
Emp. Form.:
C35H30ClF4N5O3S2
Mol. Mass.:
744.221
SMILES:
Cc1c-2c(CSCc3cc(CSc4cc(OCCCn5c(C(O)=O)c(c6c-2c(Cl)ccc56)C(F)(F)F)c2ccc(F)cc2c4)n(C)n3)nn1C
Structure:
Search PDB for entries with ligand similarity: